CA3117841A1 - Orthogonal protein heterodimers - Google Patents

Orthogonal protein heterodimers Download PDF

Info

Publication number
CA3117841A1
CA3117841A1 CA3117841A CA3117841A CA3117841A1 CA 3117841 A1 CA3117841 A1 CA 3117841A1 CA 3117841 A CA3117841 A CA 3117841A CA 3117841 A CA3117841 A CA 3117841A CA 3117841 A1 CA3117841 A1 CA 3117841A1
Authority
CA
Canada
Prior art keywords
polypeptide
seq
target
monomer
amino acid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CA3117841A
Other languages
English (en)
French (fr)
Inventor
Zibo CHEN
Scott BOYKEN
Sherry BERMEO
Robert A. LANGAN
David Baker
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
WASHINGTON, University of
Original Assignee
WASHINGTON, University of
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by WASHINGTON, University of filed Critical WASHINGTON, University of
Publication of CA3117841A1 publication Critical patent/CA3117841A1/en
Pending legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B82—NANOTECHNOLOGY
    • B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
    • B82Y10/00—Nanotechnology for information processing, storage or transmission, e.g. quantum computing or single electron logic
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B82—NANOTECHNOLOGY
    • B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
    • B82Y15/00—Nanotechnology for interacting, sensing or actuating, e.g. quantum dots as markers in protein assays or molecular motors
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B82—NANOTECHNOLOGY
    • B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
    • B82Y5/00—Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K19/00—Hybrid peptides, i.e. peptides covalently bound to nucleic acids, or non-covalently bound protein-protein complexes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/62—DNA sequences coding for fusion proteins
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6803—General methods of protein analysis not limited to specific proteins or families of proteins
    • G01N33/6845—Methods of identifying protein-protein interactions in protein mixtures
    • G—PHYSICS
    • G06—COMPUTING OR CALCULATING; COUNTING
    • G06N—COMPUTING ARRANGEMENTS BASED ON SPECIFIC COMPUTATIONAL MODELS
    • G06N3/00—Computing arrangements based on biological models
    • G06N3/002—Biomolecular computers, i.e. using biomolecules, proteins, cells
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
    • G16B15/00—ICT specially adapted for analysing two-dimensional [2D] or three-dimensional [3D] molecular structures, e.g. structural or functional relations or structure alignment
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
    • G16B5/00—ICT specially adapted for modelling or simulations in systems biology, e.g. gene-regulatory networks, protein interaction networks or metabolic networks
    • H—ELECTRICITY
    • H03—ELECTRONIC CIRCUITRY
    • H03K—PULSE TECHNIQUE
    • H03K19/00—Logic circuits, i.e. having at least two inputs acting on one output; Inverting circuits
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/536—Immunoassay; Biospecific binding assay; Materials therefor with immune complex formed in liquid phase
    • G01N33/542—Immunoassay; Biospecific binding assay; Materials therefor with immune complex formed in liquid phase with steric inhibition or signal modification, e.g. fluorescent quenching
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
    • G16B5/00—ICT specially adapted for modelling or simulations in systems biology, e.g. gene-regulatory networks, protein interaction networks or metabolic networks
    • G16B5/10—Boolean models
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
    • G16B5/00—ICT specially adapted for modelling or simulations in systems biology, e.g. gene-regulatory networks, protein interaction networks or metabolic networks
    • G16B5/30—Dynamic-time models
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S977/00—Nanotechnology
    • Y10S977/902—Specified use of nanostructure
    • Y10S977/904—Specified use of nanostructure for medical, immunological, body treatment, or diagnosis
    • Y10S977/914—Protein engineering

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Physics & Mathematics (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Nanotechnology (AREA)
  • Immunology (AREA)
  • Theoretical Computer Science (AREA)
  • General Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Spectroscopy & Molecular Physics (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Toxicology (AREA)
  • Medical Informatics (AREA)
  • Mathematical Physics (AREA)
  • Bioinformatics & Computational Biology (AREA)
  • Food Science & Technology (AREA)
  • Analytical Chemistry (AREA)
  • Cell Biology (AREA)
  • Pathology (AREA)
  • Computing Systems (AREA)
  • Evolutionary Biology (AREA)
  • Wood Science & Technology (AREA)
  • Artificial Intelligence (AREA)
CA3117841A 2018-11-02 2019-11-04 Orthogonal protein heterodimers Pending CA3117841A1 (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US201862755264P 2018-11-02 2018-11-02
US62/755,264 2018-11-02
US201962904800P 2019-09-24 2019-09-24
US62/904,800 2019-09-24
PCT/US2019/059654 WO2020093043A1 (en) 2018-11-02 2019-11-04 Orthogonal protein heterodimers

Publications (1)

Publication Number Publication Date
CA3117841A1 true CA3117841A1 (en) 2020-05-07

Family

ID=68655751

Family Applications (1)

Application Number Title Priority Date Filing Date
CA3117841A Pending CA3117841A1 (en) 2018-11-02 2019-11-04 Orthogonal protein heterodimers

Country Status (8)

Country Link
US (4) US11820800B2 (cg-RX-API-DMAC7.html)
EP (1) EP3873919A1 (cg-RX-API-DMAC7.html)
JP (2) JP2022505866A (cg-RX-API-DMAC7.html)
KR (1) KR20210087959A (cg-RX-API-DMAC7.html)
CN (1) CN113272317A (cg-RX-API-DMAC7.html)
AU (1) AU2019371462A1 (cg-RX-API-DMAC7.html)
CA (1) CA3117841A1 (cg-RX-API-DMAC7.html)
WO (1) WO2020093043A1 (cg-RX-API-DMAC7.html)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20210087959A (ko) * 2018-11-02 2021-07-13 유니버시티 오브 워싱톤 직교 단백질 이종이량체
US20230399660A1 (en) * 2020-10-23 2023-12-14 Altius Institute For Biomedical Sciences Cell Permeable Proteins for Genome Engineering
WO2022169913A2 (en) * 2021-02-02 2022-08-11 Outpace Bio, Inc. Synthetic degrader system for targeted protein degradation
WO2023288190A1 (en) * 2021-07-13 2023-01-19 University Of Washington Modular reconfigurable asymmetric protein assemblies
WO2023150649A2 (en) * 2022-02-02 2023-08-10 Outpace Bio, Inc. Synthetic degrader system for targeted protein degradation
US20250136652A1 (en) * 2022-03-02 2025-05-01 The Regents Of The University Of California Fusion protein for targeting recombinant proteins for degradation
WO2024026465A1 (en) * 2022-07-29 2024-02-01 The Broad Institute, Inc. Programmable pattern recognition compositions
WO2026055533A1 (en) * 2024-09-06 2026-03-12 The Regents Of The University Of California Synthetic receptors for engineered ligands

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1997012988A1 (en) * 1995-10-06 1997-04-10 Pence Coiled-coil heterodimer methods and compositions for the detection and purification of expressed proteins
NZ507886A (en) * 1998-05-19 2003-05-30 Avidex Ltd Multivalent T cell receptor complexes
WO2004007530A2 (en) * 2002-07-17 2004-01-22 The Center For Blood Research, Inc. Modified proteins stabilized in a desired conformation and methods for producing same
DK1999154T3 (da) 2006-03-24 2012-12-03 Merck Patent Gmbh Fremstillede heterodimere proteindomæner
US9217011B2 (en) * 2007-09-07 2015-12-22 Complix Nv Non-natural proteinaceous scaffold made of three non-covalently associated peptides
US20110224404A1 (en) 2010-03-11 2011-09-15 Florida State University Research Foundation Method for development of a peptide building block useful for de novo protein design
EP3436470A4 (en) 2016-04-01 2019-11-20 University of Washington POLYPEPTIDES FOR THE PREPARATION OF HOMOOLIGOMERS WITH MODULAR HYDROGEN BONDING NETWORKED SPECIFICITY AND THEIR DESIGN
US20180068054A1 (en) * 2016-09-06 2018-03-08 University Of Washington Hyperstable Constrained Peptides and Their Design
US10818377B2 (en) * 2016-11-16 2020-10-27 University Of Washington Computational design of self-assembling cyclic protein homo-oligomers
US20210363214A1 (en) * 2018-03-01 2021-11-25 University Of Washington Transmembrane polypeptides
CN112512544B (zh) * 2018-07-19 2025-09-09 华盛顿大学 蛋白质开关的全新设计
US20210324011A1 (en) * 2018-10-25 2021-10-21 University Of Washington Self-assembling protein homo-polymers
KR20210087959A (ko) * 2018-11-02 2021-07-13 유니버시티 오브 워싱톤 직교 단백질 이종이량체
KR20210111761A (ko) * 2018-12-04 2021-09-13 유니버시티 오브 워싱턴 단백질 기능 및 상호작용을 제어하기 위한 시약 및 방법
US12583896B2 (en) * 2019-01-07 2026-03-24 The Regents Of The University Of California Caged-degron-based molecular feedback circuits and methods of using the same
EP3908592A1 (en) * 2019-01-07 2021-11-17 University of Washington De novo design of protein switches for tunable control of protein degradation
WO2020214549A1 (en) * 2019-04-15 2020-10-22 University Of Washington Self-assembling 2d arrays with de novo protein building blocks
US20220144895A1 (en) * 2019-04-18 2022-05-12 University Of Washington De novo design of tunable ph-driven conformational switches
WO2020257225A1 (en) * 2019-06-17 2020-12-24 University Of Washington De novo design of phosphorylation inducible protein switches (phospho-switches)
WO2021158849A1 (en) * 2020-02-07 2021-08-12 University Of Washington Multipartite and circularly permuted beta-barrel polypeptides and methods for their use

Also Published As

Publication number Publication date
US20220017579A1 (en) 2022-01-20
AU2019371462A1 (en) 2021-05-20
JP2024149492A (ja) 2024-10-18
WO2020093043A1 (en) 2020-05-07
JP2022505866A (ja) 2022-01-14
CN113272317A (zh) 2021-08-17
US20220098250A1 (en) 2022-03-31
EP3873919A1 (en) 2021-09-08
US20210355175A1 (en) 2021-11-18
KR20210087959A (ko) 2021-07-13
US11820800B2 (en) 2023-11-21
US20240101615A1 (en) 2024-03-28

Similar Documents

Publication Publication Date Title
US20240101615A1 (en) Orthogonal protein heterodimers
Tiede et al. Adhiron: a stable and versatile peptide display scaffold for molecular recognition applications
US12304927B2 (en) De novo design of protein switches
Seeger et al. Design, construction, and characterization of a second‐generation DARPin library with reduced hydrophobicity
US10844370B2 (en) Scaffold proteins derived from plant cystatins
Béhar et al. Tolerance of the archaeal Sac7d scaffold protein to alternative library designs: characterization of anti-immunoglobulin G Affitins
Edgell et al. De novo designed protein-interaction modules for in-cell applications
Jagadish et al. Recombinant expression of cyclotides using split inteins
JP5904565B2 (ja) 微小タンパク質の骨格構造に基づく分子ライブラリ
Patel et al. Selection of a high-affinity WW domain against the extracellular region of VEGF receptor isoform-2 from a combinatorial library using CIS display
Lorenz et al. The filamentous phages fd and IF1 use different mechanisms to infect Escherichia coli
US20240368233A1 (en) Modular reconfigurable asymmetric protein assemblies
Bang et al. Role of a salt bridge in the model protein crambin explored by chemical protein synthesis: X-ray structure of a unique protein analogue,[V15A] crambin-α-carboxamide
Petters et al. Design, expression and characterization of a highly stable tetratricopeptide-based protein scaffold for phage display application
Nikolaev et al. Rethinking Leucine Zipper–a ubiquitous signal transduction motif
Manczyk Structural and Functional Characterization of Ubiquitin Variants and Ubiquitin Binding Proteins
Khairil Extending the scope of covalent peptide-protein conjugation: from purification to expanded nanoassembly
Chen Programmable Design of Protein Interaction Specificity and Logic Gates
Hartje Relationships between Hydrogen Bonds and Halogen Bonds in Biomolecular Engineering
Nagy Structural Analysis of an Essential Core Component of the Nuclear Pore Complex
HK1217915B (en) Scaffold proteins derived from plant cystatins

Legal Events

Date Code Title Description
EEER Examination request

Effective date: 20231101

MFA Maintenance fee for application paid

Free format text: FEE DESCRIPTION TEXT: MF (APPLICATION, 5TH ANNIV.) - STANDARD

Year of fee payment: 5

U00 Fee paid

Free format text: ST27 STATUS EVENT CODE: A-2-2-U10-U00-U101 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: MAINTENANCE REQUEST RECEIVED

Effective date: 20241025

U11 Full renewal or maintenance fee paid

Free format text: ST27 STATUS EVENT CODE: A-2-2-U10-U11-U102 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: MAINTENANCE FEE PAYMENT DETERMINED COMPLIANT

Effective date: 20241025

Free format text: ST27 STATUS EVENT CODE: A-2-2-U10-U11-U102 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: MAINTENANCE FEE PAYMENT PAID IN FULL

Effective date: 20241025

MFA Maintenance fee for application paid

Free format text: FEE DESCRIPTION TEXT: MF (APPLICATION, 6TH ANNIV.) - STANDARD

Year of fee payment: 6

U00 Fee paid

Free format text: ST27 STATUS EVENT CODE: A-2-2-U10-U00-U101 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: MAINTENANCE REQUEST RECEIVED

Effective date: 20241104

U11 Full renewal or maintenance fee paid

Free format text: ST27 STATUS EVENT CODE: A-2-2-U10-U11-U102 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: MAINTENANCE FEE PAYMENT DETERMINED COMPLIANT

Effective date: 20241104

Free format text: ST27 STATUS EVENT CODE: A-2-2-U10-U11-U102 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: MAINTENANCE FEE PAYMENT PAID IN FULL

Effective date: 20241104

D15 Examination report completed

Free format text: ST27 STATUS EVENT CODE: A-2-2-D10-D15-D126 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: EXAMINER'S REPORT

Effective date: 20250114

B12 Application deemed to be withdrawn, abandoned or lapsed

Free format text: ST27 STATUS EVENT CODE: N-2-6-B10-B12-B303 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: DEEMED ABANDONED - FAILURE TO RESPOND TO AN EXAMINER'S REQUISITION

Effective date: 20250514